
Revvity Inc (RVTY) - Product Pipeline Analysis, 2024 Update
Description
Revvity Inc (RVTY) - Product Pipeline Analysis, 2024 Update
Summary
Revvity Inc (Revvity), formerly Perkinelmer Inc, offers products, services, and solutions for the diagnostics, life sciences, and applied markets. The company offers reagents, instruments, assay platforms and software to hospitals, clinicians, medical labs and medical research professionals. Revvity also offers cord blood and tissue banking, laboratory and research services. Its products find application in atomic spectroscopy, cell imaging and analysis, chromatography, analysis and detection, DNA/RNA isolation, in vivo imaging, molecular spectroscopy, protein analysis and detection, and tissue imaging, among others. The company operates in Asia, Europe, and Americas. Revvity is headquartered in Waltham, Massachusetts, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Revvity Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
97 Pages
- Revvity Inc Company Overview
- Revvity Inc Company Snapshot
- Revvity Inc Pipeline Products and Ongoing Clinical Trials Overview
- Revvity Inc – Pipeline Analysis Overview
- Business Description
- Revvity Inc - Key Facts
- Revvity Inc - Major Products and Services
- Revvity Inc Pipeline Products by Development Stage
- Revvity Inc Ongoing Clinical Trials by Trial Status
- Revvity Inc Pipeline Products Overview
- Accentis - Allergy
- Accentis - Allergy Product Overview
- Accentis - Autoimmune Disorders I5:I36Accentis - Autoimmune Disorders Product Overview
- Accentis - Endocrine Disorders
- Accentis - Endocrine Disorders Product Overview
- Accentis - Infectious Diseases
- Accentis - Infectious Diseases Product Overview
- Anti-SARS-CoV-2 Elisa (IgA)
- Anti-SARS-CoV-2 Elisa (IgA) Product Overview
- Anti-SARS-CoV-2 Elisa (IgA) Clinical Trial
- Anti-SARS-CoV-2 QuantiVac ELISA (IgG) Assay
- Anti-SARS-CoV-2 QuantiVac ELISA (IgG) Assay Product Overview
- Dexela Flat Panel X-ray Detector 2321
- Dexela Flat Panel X-ray Detector 2321 Product Overview
- Diagnostic Kit - Candida Krusei
- Diagnostic Kit - Candida Krusei Product Overview
- Diagnostic Kit - Candida Tropicalis
- Diagnostic Kit - Candida Tropicalis Product Overview
- Diagnostic Kit - Rubella Virus
- Diagnostic Kit - Rubella Virus Product Overview
- Diagnostic Kit - Yersinia Enterocolitica
- Diagnostic Kit - Yersinia Enterocolitica Product Overview
- Diagnostic Test - Chagas Disease
- Diagnostic Test - Chagas Disease Product Overview
- Diagnostic Test - HIV
- Diagnostic Test - HIV Product Overview
- Diagnostic Test - Preterm Birth
- Diagnostic Test - Preterm Birth Product Overview
- Dry Blood Spot Test - COVID 19
- Dry Blood Spot Test - COVID 19 Product Overview
- Evoya
- Evoya Product Overview
- GENLISA Human Anti SARS-CoV-2 Nucleocapsid Protein IgG ELISA
- GENLISA Human Anti SARS-CoV-2 Nucleocapsid Protein IgG ELISA Product Overview
- GENLISA Human Anti SARS-CoV-2 Spike Protein IgG ELISA
- GENLISA Human Anti SARS-CoV-2 Spike Protein IgG ELISA Product Overview
- GENLISA Human SARS-CoV-2 Spike Protein Antigen ELISA
- GENLISA Human SARS-CoV-2 Spike Protein Antigen ELISA Product Overview
- Human DcCoV Antigen ELISA
- Human DcCoV Antigen ELISA Product Overview
- Human HCoV-229E Antigen ELISA
- Human HCoV-229E Antigen ELISA Product Overview
- Human HCoV-HKU1 Antigen ELISA
- Human HCoV-HKU1 Antigen ELISA Product Overview
- Human HCoV-NL63 Antigen ELISA
- Human HCoV-NL63 Antigen ELISA Product Overview
- Human HCoV-OC43 Antigen ELISA
- Human HCoV-OC43 Antigen ELISA Product Overview
- Human MERS-CoV Antigen ELISA
- Human MERS-CoV Antigen ELISA Product Overview
- Human SARS-CoV Antigen ELISA
- Human SARS-CoV Antigen ELISA Product Overview
- IDS-i10 - Infectious Disease Assay
- IDS-i10 - Infectious Disease Assay Product Overview
- IDS-i10 - Allergy Assay
- IDS-i10 - Allergy Assay Product Overview
- IDS-iSYS - 17-beta Estradiol Assay
- IDS-iSYS - 17-beta Estradiol Assay Product Overview
- IDS-iSYS - Androstenedione Assay
- IDS-iSYS - Androstenedione Assay Product Overview
- IDS-iSYS - DHEA-S
- IDS-iSYS - DHEA-S Product Overview
- IDS-iSYS Bioactive PTH (1-84) Kit
- IDS-iSYS Bioactive PTH (1-84) Kit Product Overview
- IgE Allergy Test - DP 3134-1601-1 E
- IgE Allergy Test - DP 3134-1601-1 E Product Overview
- IgE Allergy Test - DP 3134-1601-2 E
- IgE Allergy Test - DP 3134-1601-2 E Product Overview
- Lyme C6/C10 Rapid Test
- Lyme C6/C10 Rapid Test Product Overview
- Optical Scatter Imaging System - Cancer
- Optical Scatter Imaging System - Cancer Product Overview
- PerkinElmer Five-Plex qPCR Assay
- PerkinElmer Five-Plex qPCR Assay Product Overview
- PerkinElmer New Coronavirus Nucleic Acid Detection Kit - Saliva
- PerkinElmer New Coronavirus Nucleic Acid Detection Kit - Saliva Product Overview
- RA Analyzer 10
- RA Analyzer 10 Product Overview
- Rapid Test - COVID-19
- Rapid Test - COVID-19 Product Overview
- Rapid Test Kit - MethylGlyoxal
- Rapid Test Kit - MethylGlyoxal Product Overview
- SARS Diagnostic Test
- SARS Diagnostic Test Product Overview
- SARS-CoV-2 Interferon-gamma Release Assay
- SARS-CoV-2 Interferon-gamma Release Assay Product Overview
- uChek Universal
- ViaCyte
- ViaCyte Product Overview
- Revvity Inc - Key Competitors
- Revvity Inc - Key Employees
- Revvity Inc - Key Employee Biographies
- Revvity Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Joint Venture
- Recent Developments
- Revvity Inc, Recent Developments
- Apr 29, 2024: Revvity Announces Financial Results for the First Quarter of 2024
- Apr 26, 2024: EUROIMMUN and ALPCO-GeneProof partner for CE-IVD assays
- Apr 25, 2024: Early Check Newborn Screening Study Taps Revvity to Provide Genome Sequencing
- Apr 15, 2024: Revvity Signals Software’s New Synergy Solution Redefines Collaboration between Pharma and Contract Partners
- Apr 02, 2024: Preliminary Injunction Granted to Enforce Revvity’s Rights and Cloud Software Group’s Obligations Related to Spotfire Software
- Mar 18, 2024: Celonic Launches the New GS-CHOVOLUTION System Based on Revvity’s CHOSOURCE Expression Platform
- Mar 18, 2024: Revvity launches newborn sequencing research workflow
- Mar 15, 2024: Revvity Introduces New Workflow to Accelerate Newborn Sequencing Research
- Feb 12, 2024: Revvity Signals Software Unveils Signals Clinical Solution to Accelerate Critical Clinical Trial Insights and Data-Driven Decisions
- Jan 25, 2024: Revvity Elects Sophie Vandebroek and Michael Klobuchar to its Board of Directors
- Appendix
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Table 1: Revvity Inc Pipeline Products and Ongoing Clinical Trials Overview
- Table 2: Revvity Inc Pipeline Products by Equipment Type
- Table 3: Revvity Inc Pipeline Products by Indication
- Table 4: Revvity Inc, Key Facts
- Table 5: Revvity Inc, Major Products and Services
- Table 6: Revvity Inc Number of Pipeline Products by Development Stage
- Table 7: Revvity Inc Pipeline Products Summary by Development Stage
- Table 8: Revvity Inc Ongoing Clinical Trials by Trial Status
- Table 9: Revvity Inc Ongoing Clinical Trials Summary
- Table 10: Accentis - Allergy - Product Status
- Table 11: Accentis - Allergy - Product Description
- Table 12: Accentis - Autoimmune Disorders - Product Status
- Table 13: Accentis - Autoimmune Disorders - Product Description
- Table 14: Accentis - Endocrine Disorders - Product Status
- Table 15: Accentis - Endocrine Disorders - Product Description
- Table 16: Accentis - Infectious Diseases - Product Status
- Table 17: Accentis - Infectious Diseases - Product Description
- Table 18: Anti-SARS-CoV-2 Elisa (IgA) - Product Status
- Table 19: Anti-SARS-CoV-2 Elisa (IgA) - Product Description
- Table 20: Anti-SARS-CoV-2 Elisa (IgA) - Protocol for the Collection of Clinical Samples for Evaluation and Implementation of Serological Techniques for Screening for COVID-19 Infection at the University Hospital of Rouen
- Table 21: Anti-SARS-CoV-2 QuantiVac ELISA (IgG) Assay - Product Status
- Table 22: Anti-SARS-CoV-2 QuantiVac ELISA (IgG) Assay - Product Description
- Table 23: Dexela Flat Panel X-ray Detector 2321 - Product Status
- Table 24: Dexela Flat Panel X-ray Detector 2321 - Product Description
- Table 25: Diagnostic Kit - Candida Krusei - Product Status
- Table 26: Diagnostic Kit - Candida Krusei - Product Description
- Table 27: Diagnostic Kit - Candida Tropicalis - Product Status
- Table 28: Diagnostic Kit - Candida Tropicalis - Product Description
- Table 29: Diagnostic Kit - Rubella Virus - Product Status
- Table 30: Diagnostic Kit - Rubella Virus - Product Description
- Table 31: Diagnostic Kit - Yersinia Enterocolitica - Product Status
- Table 32: Diagnostic Kit - Yersinia Enterocolitica - Product Description
- Table 33: Diagnostic Test - Chagas Disease - Product Status
- Table 34: Diagnostic Test - Chagas Disease - Product Description
- Table 35: Diagnostic Test - HIV - Product Status
- Table 36: Diagnostic Test - HIV - Product Description
- Table 37: Diagnostic Test - Preterm Birth - Product Status
- Table 38: Diagnostic Test - Preterm Birth - Product Description
- Table 39: Dry Blood Spot Test - COVID 19 - Product Status
- Table 40: Dry Blood Spot Test - COVID 19 - Product Description
- Table 41: Evoya - Product Status
- Table 42: Evoya - Product Description
- Table 43: GENLISA Human Anti SARS-CoV-2 Nucleocapsid Protein IgG ELISA - Product Status
- Table 44: GENLISA Human Anti SARS-CoV-2 Nucleocapsid Protein IgG ELISA - Product Description
- Table 45: GENLISA Human Anti SARS-CoV-2 Spike Protein IgG ELISA - Product Status
- Table 46: GENLISA Human Anti SARS-CoV-2 Spike Protein IgG ELISA - Product Description
- Table 47: GENLISA Human SARS-CoV-2 Spike Protein Antigen ELISA - Product Status
- Table 48: GENLISA Human SARS-CoV-2 Spike Protein Antigen ELISA - Product Description
- Table 49: Human DcCoV Antigen ELISA - Product Status
- Table 50: Human DcCoV Antigen ELISA - Product Description
- Table 51: Human HCoV-229E Antigen ELISA - Product Status
- Table 52: Human HCoV-229E Antigen ELISA - Product Description
- Table 53: Human HCoV-HKU1 Antigen ELISA - Product Status
- Table 54: Human HCoV-HKU1 Antigen ELISA - Product Description
- Table 55: Human HCoV-NL63 Antigen ELISA - Product Status
- Table 56: Human HCoV-NL63 Antigen ELISA - Product Description
- Table 57: Human HCoV-OC43 Antigen ELISA - Product Status
- Table 58: Human HCoV-OC43 Antigen ELISA - Product Description
- Table 59: Human MERS-CoV Antigen ELISA - Product Status
- Table 60: Human MERS-CoV Antigen ELISA - Product Description
- Table 61: Human SARS-CoV Antigen ELISA - Product Status
- Table 62: Human SARS-CoV Antigen ELISA - Product Description
- Table 63: IDS-i10 - Infectious Disease Assay - Product Status
- Table 64: IDS-i10 - Infectious Disease Assay - Product Description
- Table 65: IDS-i10 - Allergy Assay - Product Status
- Table 66: IDS-i10 - Allergy Assay - Product Description
- Table 67: IDS-iSYS - 17-beta Estradiol Assay - Product Status
- Table 68: IDS-iSYS - 17-beta Estradiol Assay - Product Description
- Table 69: IDS-iSYS - Androstenedione Assay - Product Status
- Table 70: IDS-iSYS - Androstenedione Assay - Product Description
- Table 71: IDS-iSYS - DHEA-S - Product Status
- Table 72: IDS-iSYS - DHEA-S - Product Description
- Table 73: IDS-iSYS Bioactive PTH (1-84) Kit - Product Status
- Table 74: IDS-iSYS Bioactive PTH (1-84) Kit - Product Description
- Table 75: IgE Allergy Test - DP 3134-1601-1 E - Product Status
- Table 76: IgE Allergy Test - DP 3134-1601-1 E - Product Description
- Table 77: IgE Allergy Test - DP 3134-1601-2 E - Product Status
- Table 78: IgE Allergy Test - DP 3134-1601-2 E - Product Description
- Table 79: Lyme C6/C10 Rapid Test - Product Status
- Table 80: Lyme C6/C10 Rapid Test - Product Description
- Table 81: Optical Scatter Imaging System - Cancer - Product Status
- Table 82: Optical Scatter Imaging System - Cancer - Product Description
- Table 83: PerkinElmer Five-Plex qPCR Assay - Product Status
- Table 84: PerkinElmer Five-Plex qPCR Assay - Product Description
- Table 85: PerkinElmer New Coronavirus Nucleic Acid Detection Kit - Saliva - Product Status
- Table 86: PerkinElmer New Coronavirus Nucleic Acid Detection Kit - Saliva - Product Description
- Table 87: RA Analyzer 10 - Product Status
- Table 88: RA Analyzer 10 - Product Description
- Table 89: Rapid Test - COVID-19 - Product Status
- Table 90: Rapid Test - COVID-19 - Product Description
- Table 91: Rapid Test Kit - MethylGlyoxal - Product Status
- Table 92: Rapid Test Kit - MethylGlyoxal - Product Description
- Table 93: SARS Diagnostic Test - Product Status
- Table 94: SARS Diagnostic Test - Product Description
- Table 95: SARS-CoV-2 Interferon-gamma Release Assay - Product Status
- Table 96: SARS-CoV-2 Interferon-gamma Release Assay - Product Description
- Table 97: uChek Universal - Product Description
- Table 98: ViaCyte - Product Status
- Table 99: ViaCyte - Product Description
- Table 100: Revvity Inc, Key Employees
- Table 101: Revvity Inc, Key Employee Biographies
- Table 102: Revvity Inc, Other Locations
- Table 103: Revvity Inc, Subsidiaries
- Table 104: Revvity Inc, Joint Venture
- Table 105: Glossary
- List of Figures
- Figure 1: Revvity Inc Pipeline Products by Equipment Type
- Figure 2: Revvity Inc Pipeline Products by Development Stage
- Figure 3: Revvity Inc Ongoing Clinical Trials by Trial Status
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.